Characterization of response and corneal events with extended follow-up after belantamab mafodotin (GSK2857916) monotherapy for patients with relapsed multiple myeloma: a case series from the first-time-in-human clinical trial
- Publication date
- 1 May 2020
- Publisher
- 'Ferrata Storti Foundation (Haematologica)'